000 01428nam##2200349za#4500
0019.536892
003CaOODSP
00520210615084525
007ta
008150406|2002||||xxc|||||     f|0| 0 eng|d
020 |a0-660-62143-6
040 |aCaOODSP|beng
041 |aeng
041 |afre
043 |an-cn---
0861 |aBT31-4/64-2002
1101 |aCanada. |bTreasury Board.
24510|aPatented Medicine Prices Review Board Canada
260 |aOttawa - Ontario : |bTreasury Board of Canada Secretariat |c2002.
300 |a33p. : |bgraphs, tables ; |c28 cm.
4901 |aPerformance report for the period ending March 31, 2002
500 |aIncorrect catalogue number (BT31-4/86-2002) and ISBN (0-660-62087-1) printed in this publication.
563 |aSoftcover
590 |a02-46|b2002-11-15
69007|aDrugs|2gcpds
69007|aEstimates|2gcpds
69007|aFederal institutions|2gcpds
69007|aPrices|2gcpds
7760#|tPatented Medicine Prices Review Board Canada, performance report for the period ending March 31, 2002 |w(CaOODSP)9.573012
7760#|tConseil d'examen du prix des médicaments brevetés Canada, rapport sur le rendement pour la période se terminant le 31 mars 2002 |w(CaOODSP)9.603254
792 |tConseil d'examen du prix des médicaments brevetés Canada |w(CaOODSP)9.536893
830#0|aPerformance report for the period ending March 31, 2002.|w(CaOODSP)9.510738